ERK5 regulation in naïve T-cell activation and survival

European Journal of Immunology

Volumn 38, Issue 9, 2008, Pages 2534-2547

  Ananieva, Olga ^a   Macdonald, Andrew ^a,c   Wang, Xin ^b   McCoy, Claire E ^a,d   McIlrath, Joanne ^a   Tournier, Cathy ^b   Arthur, J Simon C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Kinases; Klf2; MAPK; Signal transduction; T cells

Indexed keywords

CHEMOKINE RECEPTOR CCR7; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 2; L SELECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 7; NUCLEAR RECEPTOR NUR77; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CCR7 PROTEIN, MOUSE; DNA BINDING PROTEIN; KLF2 PROTEIN, MOUSE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STEROID RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE INDUCTION; KNOCKOUT GENE; LYMPH NODE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE ACTIVATION; TRANSGENE; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE;

ANIMALS; CELL SURVIVAL; DNA-BINDING PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 7; RECEPTORS, CCR7; RECEPTORS, LYSOSPHINGOLIPID; RECEPTORS, STEROID; T-LYMPHOCYTES;

EID: 55249112351     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200737867     Document Type: Article

References (52)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S., The protein kinase complement of the human genome. Science 2002. 298: 1912-1934.
2. Nishimoto, S. and Nishida, E., MAPK signalling'. ERK5 versus ERK1/ 2. EMBO Rep. 2006. 7: 782-786.
3. Cuevas, B. D., Abell, A. N. and Johnson, G. L., Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007. 26: 3159-3171.
4. Rubinfeld, H. and Seger, R., The ERK cascade: A prototype of MAPK signaling. Mol. Biotechnol. 2005. 31: 151-174.
5. Raman, M., Chen, W. and Cobb, M. H., Differential regulation and properties of MAPKs. Oncogene 2007. 26: 3100-3112.
6. Wang, X. and Tournier, C., Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 2006. 18: 753-760.
7. Coulombe, P. and Meloche, S. Atypical mitogen-activated protein kinases: Structure, regulation and functions. Biochim. Biophys. Acta. 2006. 1773: 1376-1387.
8. Kondoh, K., Terasawa, K., Morimoto, H. and Nishida, E., Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms. Mol. Cell Biol. 2006. 26: 1679-1690.
9. Kasler, H. G., Victoria, J., Duramad, O. and Winoto, A., ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell Biol. 2000. 20: 8382-8389.
10. Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J. and Lee, J. D., Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998. 395: 713-716.
11. Abe, J., Kusuhara, M., Ulevitch, R. J., Berk, B. C. and Lee, J. D., Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 1996. 271: 16586-16590.
12. Zhou, G., Bao, Z. Q. and Dixon, J. E., Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 1995. 270: 12665-12669.
13. Wang, X., Merritt, A. J., Seyfried, J., Guo, C., Papadakis, E. S., Finegan, K. G., Kayahara, M. et al., Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol. Cell Biol. 2005. 25: 336-345.
14. Sun, W., Wei, X., Kesavan, K., Garrington, T. P., Fan, R., Mei, J., Anderson, S. M. et al., MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol. Cell Biol. 2003. 23: 2298-2308.
15. Kesavan, K., Lobel-Rice, K., Sun, W., Lapadat, R., Webb, S., Johnson, G. L. and Garrington, T. P., MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. J. Cell Physiol. 2004. 199: 140-148.
16. Yang, J., Boerm, M., McCarty, M., Bucana, C., Fidler, I. J., Zhuang, Y. and Su, B., Mekk3 is essential for early embryonic cardiovascular development, Nat. Genet. 2000. 24: 309-313.
17. Chao, T. H., Hayashi, M., Tapping, R. I., Kato, Y. and Lee, J. D., MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 1999. 274: 36035-36038.
18. Sun, W., Kesavan, K., Schaefer, B. C., Garrington, T. P., Ware, M., Johnson, N. L., Gelfand, E. W. and Johnson, G. L., MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 2001. 276: 5093-5100.
19. Wang, X., Finegan, K. G., Robinson, A. C., Knowles, L., Khasravi-Far, R., Hinchliffe, K. A., Boat-Handford, R. P. et al., Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress. Cell Death Differ. 2006. 13: 2099-2108.
20. Regan, C. P., Li, W., Boucher, D. M., Spatz, S., Su, M. S. and Kuida, K., Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. USA 2002. 99: 9248-9253.
21. Yan, L., Carr, J., Ashby, P. R., Murry-Tait, V., Thompson, C. and Arthur, J. S., Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Dev. Biol. 2003. 3: 11.
22. Sohn, S. J., Sarvis, B. K., Cado, D. and Virmoto, A., ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J. Biol. Chem. 2002. 277: 43344-43351.
23. Hayashi, M., Kim, S. W., Imanaka-Yoshida, K., Yoshida, T., Abel, E. D., Eliceiri, B., Yang, Y. et al., Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest. 2004. 113: 1138-1148.
24. Pi, X., Yan, C. and Berk, B. C., Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ. Res. 2004. 94: 362-369.
25. Pi, X., Garin, G., Xie, L., Zheng, Q., Wei, H., Abe, J., Yan, C. and Berk, B. C., BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circ. Res. 2005. 96: 1145-1151.
26. Liu, L., Cundiff, P., Abel, G., Wang, Y., Faigle, R., Sakagami, H., Xu, M. and Xia, Z., Extracellular signal-regulated kinase (ERK) 5 is necessary and sufficient to specify cortical neuronal fate. Proc. Natl. Acad. Sci. USA 2006. 103: 9697-9702.
27. Nishimoto, S., Kusakabe, M. and Nishida, E., Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development. EMBO Rep. 2005. 6: 1064-1069.
28. Sohn, S. J., Li, D., Lee, L. K. and Winoto, A., Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase. Mol. Cell Biol. 2005. 25: 8553-8566.
29. Garaude, J., Cherni, S., Kaminski, S., Delepine, E., Chable-Bessia, C., Benkirane, M., Borges, J. et al., ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo. J. Immunol. 2006. 177: 7607-7617.
30. Garaude, J., Kaminski, S., Cherni, S., Hipskind, R. A. and Villalba, M., The role of ERK5 in T-cell signalling. Scand. J. Immunol. 2005. 62: 515-520.
31. Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J. and Lee, J. D., BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo J. 1997. 16: 7054-7066.
32. Yang, C. C., Ornatsky, O. I., McDermott, J. C., Cruz, T. F. and Prody, C. A., Interaction of myocyte enhancer factor 2 (MEF2) with a mitogenactivated protein kinase, ERK5/BMK1. Nucleic Acids Res. 1998. 26: 4771-4777.
33. Kato, Y., Zhao, M., Morikawa, A., Sugiyama, T., Chakravortty, D., Koide, N., Yoshida, T. et al., Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 2000. 275: 18534-18540.
34. Winoto, A. and Littman, D.R., Nuclear hormone receptors in T lymphocytes. Cell 2002. 109: S57-S66.
35. Darragh, J., Soloaga, A., Beardmore, V. A., Wingate, A. D., Wiggin, G. R., Peggie, M. and Arthur, J. S., MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem. J. 2005. 390: 749-759.
36. Calnan, B. J., Szychowski, S., Chan, F. K., Cado, D. and Winoto, A., A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995. 3: 273-282.
37. Lee, S. L., Wesselschmidt, R. L., Linette, G. P., Kanagawa, O., Russell, J. H. and Milbrandt, J., Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995. 269: 532-535.
38. Cheng, L. E., Chan, F. K., Cado, D. and Winoto, A., Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 1997. 16: 1865-1875.
39. Kuo, C. T., Veselits, M. L., Barton, K. P., Lu, M. M., Clendenin, C. and Leiden, J. M., The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 1997. 11: 2996-3006.
40. Parmar, K. M., Larman, H. B., Dai, G., Zhang, Y., Wang, E. T., Moorthy, S. N., Kratz, J. R. et al., Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest. 2006. 116: 49-58.
41. Kuo, C. T., Veselits, M. L. and Leiden, J. M., LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 1997. 277: 1986-1990.
42. Carlson, C.M., Endrizzi, B. T., Wu, J.,Ding,X., Weinreich, M.A.,Walsh, E. R., Wani, M. A. et al., Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006. 442: 299-302.
43. Tallquist, M. D. and Soriano, P., Epiblast-restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 2000. 26: 113-115.
44. de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton, T. et al., Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 2003. 33: 314-325.
45. Wei, X., Sun, W., Fan, R., Hahn, J., Joetham, A., Li, G., Webb, S. et al., MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells. Eur. J. Immunol. 2003. 33: 2903-2909.
46. Marinissen, M. J., Chiariello, M., Pallante, M. and Gutkind, J. S., A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: A role for c-Jun NH2-terminal kinase, p38s and extracellular signal-regulated kinase 5. Mol. Cell Biol. 1999. 19: 4289-4301.
47. Zhao, M., New, L., Kravchenko, V. V., Kato, Y., Gram, H., di Padova, F., Olson, E. N. et al., Regulation of the MEF2 family of transcription factors by p38. Mol. Cell Biol. 1999. 19: 21-30.
48. Mittelstadt, P. R., Salvador, J. M., Fornace Jr., A. J. and Ashwell, J. D., Activating p38 MAPK: New tricks for an old kinase. Cell Cycle 2005. 4: 1189-1192.
49. Kaiser, M., Wiggin, G. R., Lightfoot, K., Arthur, J. S. and Macdonald, A., MSK regulate TCR-induced CREB phosphorylation but not immediate early gene transcription. Eur. J. Immunol. 2007. 37: 2583-2595.
50. Lee, P. P., Fitzpatrick, D. R., Beard, C., Jessup, H. K., Lehar, S., Makar, K.W., Perez-Melgosa, M. et al., A critical role for Dnmt1 and DNA methylation in T cell development, function and survival. Immunity 2001. 15: 763-774.
51. Hinton, H. J., Alessi, D. R. and Cantrell, D. A., The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat. Immunol. 2004. 5: 539-545.
52. Mody, N., Leitch, J., Armstrong, C., Dixon, J. and Cohen, P., Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 2001. 502: 21-24.